diarrhea-predominant irritable bowel syndrome
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Conform to western medical diagnostic criteria of IBS-D; 2. Conform to diagnostic criteria of TCM syndromes of liver depression and spleen deficiency; 3. Aged 18 to 70 years, gender is not limited; 4. Subjects voluntarily participate in the trial and sign informed consent; 5. The process of obtaining informed consent should conform to ethical principles.
Exclusion criteria
Exclusion criteria: 1. Patients with organic gastrointestinal diseases; 2. Patients with severe heart, liver, kidney, respiratory, blood, and endocrine diseases; 3. Patients with mental illness and severe neurosis; 4. Women who are pregnant, breast-feeding or planning to have a pregnancy; 5. Those who have taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before being included in the trial; 6. Patients who have poor compliance with doctor's orders or are allergic to this medicine; 7. Patients who are participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intestinal flora; | — |
Secondary
| Measure | Time frame |
|---|---|
| efficacy index;mental state and quality of life assessment indicators; | — |
Countries
China
Contacts
Affiliated Hospital of Integrated Traditional Chinese and Western Medicine for Nanjing University of Chinese Medicine